We are live on ! Find out more
3NC

300 North Capital Portfolio holdings

AUM $16.3M
1-Year Est. Return 27.56%
This Fund
S&P 500
This Quarter Est. Return
+18.67%
1 Year Est. Return
+27.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$429M
AUM Growth
+$172M
Cap. Flow
+$124M
Cap. Flow %
28.82%
Top 10 Hldgs %
22.99%
Holding
130
New
19
Increased
55
Reduced
13
Closed
11

Top Buys

Rank Stock Value
1
BEAV
B/E Aerospace Inc
BEAV
+$7.4M
2
LKQ icon
LKQ Corp
LKQ
+$6.33M
3
AMG icon
Affiliated Managers Group
AMG
+$5.07M
4
WAB icon
Wabtec
WAB
+$4.75M
5
VTRS icon
Viatris
VTRS
+$4.08M

Sector Composition

Rank Sector Weight
1 Industrials 23.48%
2 Consumer Discretionary 17.36%
3 Technology 13.63%
4 Financials 9.99%
5 Healthcare 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGEN
76
DELISTED
Seagen Inc. Common Stock
SGEN
$2.21M 0.52%
50,502
+23,802
+89% +$991K
AKRX
77
DELISTED
Akorn Inc
AKRX
$2.21M 0.52%
112,340
CRM icon
78
Salesforce
CRM
$149B
$2.15M 0.5%
41,500
-5,100
-11% -$231K
PRLB icon
79
Protolabs
PRLB
$1.79B
$2.15M 0.5%
28,130
+700
+3% +$48.5K
ENOV icon
80
Enovis
ENOV
$1.65B
$2.13M 0.5%
21,880
AMZN icon
81
Amazon
AMZN
$2.87T
$2.13M 0.5%
136,000
-14,000
-9% -$209K
VIAV icon
82
Viavi Solutions
VIAV
$8.91B
$2.12M 0.49%
253,767
+32,241
+15% +$265K
GILD icon
83
Gilead Sciences
GILD
$161B
$2.1M 0.49%
+33,400
New +$2M
KSU
84
DELISTED
Kansas City Southern
KSU
$2.06M 0.48%
18,812
+16,455
+698% +$1.81M
CBST
85
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$2.06M 0.48%
32,376
+16,006
+98% +$967K
BIIB icon
86
Biogen
BIIB
$30.1B
$2.05M 0.48%
8,500
-1,100
-11% -$246K
WFM
87
DELISTED
Whole Foods Market Inc
WFM
$1.91M 0.45%
32,680
JAH
88
DELISTED
JARDEN CORPORATION
JAH
$1.85M 0.43%
+57,443
New +$1.77M
FBIN icon
89
Fortune Brands Innovations
FBIN
$5.79B
$1.63M 0.38%
45,794
CTXS
90
DELISTED
Citrix Systems Inc
CTXS
$1.58M 0.37%
+28,178
New +$1.58M
ADI icon
91
Analog Devices
ADI
$178B
$1.56M 0.36%
+33,115
New +$1.58M
PNRA
92
DELISTED
Panera Bread Co
PNRA
$1.51M 0.35%
9,540
CLDX icon
93
Celldex Therapeutics
CLDX
$2.94B
$1.48M 0.35%
+2,789
New +$956K
SBUX icon
94
Starbucks
SBUX
$120B
$1.47M 0.34%
+38,200
New +$1.37M
LBTYA icon
95
Liberty Global Class A
LBTYA
$3.57B
$1.44M 0.34%
44,134
+8,002
+22% +$259K
ALTR
96
DELISTED
Altera Corp
ALTR
$1.4M 0.33%
+37,595
New +$1.35M
VRTX icon
97
Vertex Pharmaceuticals
VRTX
$120B
$1.35M 0.31%
+17,800
New +$1.42M
RDC
98
DELISTED
Rowan Companies Plc
RDC
$1.34M 0.31%
36,620
PCYC
99
DELISTED
PHARMACYCLICS INC
PCYC
$1.27M 0.3%
9,210
META icon
100
Meta Platforms (Facebook)
META
$1.39T
$1.1M 0.26%
+22,000
New +$819K

Similar funds

300 North Capital's Q3 2013 Portfolio in Review

As of Q3 2013, 300 North Capital held 130 positions worth $429M, up 67% from $257M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

300 North Capital deployed $124M of net new capital in Q3 2013, opening 19 new positions and adding to 55 existing holdings. Its largest new stake was B/E Aerospace Inc: 145,542 shares worth $7.78M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was SOURCEFIRE INC COM STK, an estimated $1.94M trimmed.

  • 300 North Capital's largest Q3 2013 buy was B/E Aerospace Inc: 145,542 shares worth $7.78M.
  • 300 North Capital added most to Affiliated Managers Group in Q3 2013, an estimated $5.07M increase.
  • 300 North Capital's biggest Q3 2013 reduction was SOURCEFIRE INC COM STK, cutting an estimated $1.94M.
  • 300 North Capital fully exited Raymond James Financial in Q3 2013, selling an estimated $3.89M.
  • 300 North Capital's ten largest holdings make up 23% of its $429M portfolio in Q3 2013.
  • 300 North Capital opened 19 new positions and closed 11 in Q3 2013.
  • 300 North Capital's portfolio value rose 67% quarter-over-quarter to $429M.

Based on 300 North Capital's 13F filing for Q3 2013, filed 12 Nov 2013.